It has been shown that IL-18 secreted by tumor cells could elicits an expansion of NK cells overexpressing PD-L1 with immunoablative functions by reducing the number of mature NK cells and dendritic cells (DC) in a PD-L1-mediated manner, at least in the B16F10 melanoma model in mice (85). The gene discussed is IL18; the disease is neoplasm.